Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors

BACKGROUND: Better prognostic markers are needed for pancreatic endocrine tumors. Survivin is an apoptosis inhibitor that is suggested to have a negative prognostic impact in several tumor types. Contradictory data exist, especially regarding the significance of a nuclear versus cytoplasmic location...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekeblad, Sara, Lejonklou, Margareta Halin, Stålberg, Peter, Skogseid, Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348449/
https://www.ncbi.nlm.nih.gov/pubmed/22089920
http://dx.doi.org/10.1007/s00268-011-1345-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348449/
https://www.ncbi.nlm.nih.gov/pubmed/22089920
http://dx.doi.org/10.1007/s00268-011-1345-7

Ejemplares similares